MDGL (STOCKS)
Madrigal Pharmaceuticals, Inc. Common Stock
$525.670000
+6.060000 (+1.17%)
Prev close: $519.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William J. Sibold
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12,050.15M
- Employees
- 528
- P/E (TTM)
- -40.86
- P/B (TTM)
- 19.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $958.40M |
| Benefits Costs and Expenses | $1.25B |
| Costs And Expenses | $1.25B |
| Operating Expenses | $1.26B |
| Selling, General, and Administrative Expenses | $813.83M |
| Other Operating Expenses | $444.67M |
| Operating Income/Loss | -$300.10M |
| Income/Loss From Continuing Operations After Tax | -$288.28M |
| Income/Loss From Continuing Operations Before Tax | -$288.28M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$288.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$288.28M |
| Net Income/Loss Available To Common Stockholders, Basic | -$288.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$12.85 |
| Diluted Earnings Per Share | -$12.85 |
| Basic Average Shares | 22,434,310 |
| Diluted Average Shares | 22,434,310 |
| Assets | $1.26B |
| Current Assets | $1.25B |
| Inventory | $74.84M |
| Other Current Assets | $1.17B |
| Noncurrent Assets | $13.82M |
| Fixed Assets | $1.50M |
| Other Non-current Assets | $12.32M |
| Liabilities | $656.90M |
| Current Liabilities | $310.29M |
| Accounts Payable | $48.88M |
| Wages | $69.21M |
| Other Current Liabilities | $192.20M |
| Noncurrent Liabilities | $346.61M |
| Long-term Debt | $339.88M |
| Other Non-current Liabilities | $6.73M |
| Equity | $602.69M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $602.69M |
| Liabilities And Equity | $1.26B |
| Net Cash Flow From Operating Activities | -$189.55M |
| Net Cash Flow From Operating Activities, Continuing | -$189.55M |
| Net Cash Flow From Investing Activities | $32.32M |
| Net Cash Flow From Investing Activities, Continuing | $32.32M |
| Net Cash Flow From Financing Activities | $255.98M |
| Net Cash Flow From Financing Activities, Continuing | $255.98M |
| Net Cash Flow | $98.75M |
| Net Cash Flow, Continuing | $98.75M |
| Comprehensive Income/Loss | -$287.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$287.88M |
| Other Comprehensive Income/Loss | $405.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $405.00K |